The editorial accompanying the Euronet-PHL-C1 trial puts into writing the question that’s been on the minds of rad oncs for years: at what expense are ongoing clinical trials designed with an a priori bias to avoid consolidation radiation and the much overblown side effects of a small conformal field receiving 20 Gy? | Mascarin, Lancet Oncol 2023
